[Baltimore - 14 October 2012]: Bionor Pharma ASA (OSE: BIONOR) presents today research of the Company's two HIV vaccines, Vacc-C5 and Vacc-4x, and the combination of these vaccines, at the Annual International Meeting of Institute of Human Virology. The abstract will be presented by Chief Scientific Officer Maja Sommerfelt, PhD. More information about the abstract and this scientific meeting "Therapeutics for chronic and deadly viral and immune disorders" is available at Bionor`s NEW webpage:
www.bionorpharma.com."
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.